Viekirax
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Viekirax, covering 2019-10-23 to 2024-10-02. Get the full timeline:
Most recent: EMA Withdrawn: Viekirax (ombitasvir;paritaprevir;ritonavir) — AbbVie Deutschland GmbH & Co. KG